3.239.76.25
dgid:
enl:
npi:0
-Advertisement-
-Advertisement-

Neurology

DAXI emerges as promising therapy for cervical dystonia

DaxibotulinumtoxinA for Injection (DAXI) at doses of 125U and 250U showed significant efficacy in improving the symptoms of cervical dystonia (CD) compared to placebo, according to a study. The ASPEN-1 trial, a Phase 3, randomized, double-blind, placebo-controlled study, investigated the efficacy, duration of response, and safety of DAXI in adults...

Read More
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement=-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-